GLP-1 Check — India's GLP-1 Information & Self-Assessment Tool

GLP-1 & Semaglutide Blog (India)

Expert-written articles on GLP-1 therapy in India — eligibility, pricing, side-effect management, brand selection, and patient pathways. Reviewed against published Indian and international clinical evidence (RSSDI 2024 guidelines, ESI obesity guidelines, INASL fatty-liver guidelines, plus STEP, SUSTAIN, SURMOUNT, and SELECT trial data).

Compiled by the GLP-1 Check Editorial team · Updated regularly

3 articles — most recent first

What we cover

Eligibility & Indian guidelines

BMI thresholds, comorbidity criteria, RSSDI / ESI guideline interpretation, when GLP-1 is on-label vs off-label in India.

Pricing & affordability

Brand-by-brand India pricing, innovator vs generic value, post-patent-expiry pricing dynamics, hidden costs.

Side effects & management

GI side effects during titration, diet adjustment for Indian patients, rare but important events, when to seek help.

Conditions & populations

GLP-1 for PCOS, type 2 diabetes, prediabetes, NAFLD/MASH, hypertension, sleep apnea — Indian-specific considerations.

See if GLP-1 fits your profile

5-minute Indian-guideline eligibility check. BMI, comorbidities, lab values (optional) — evidence-based starting point.

Take the free assessment →